Toward imaging of alpha-synuclein with PET.
Cell
; 186(16): 3327-3329, 2023 08 03.
Article
em En
| MEDLINE
| ID: mdl-37541192
ABSTRACT
Development of radiopharmaceuticals for in vivo positron emission tomography imaging of alpha-synuclein aggregates has the potential to revolutionize Lewy body disease diagnosis and treatment. Reporting in this issue of Cell, Xiang et al. developed a high-affinity positron emission tomography tracer for alpha-synuclein.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Tomografia por Emissão de Pósitrons
/
Alfa-Sinucleína
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article